Hjem › Akut lymfoblastisk leukemi › Indiana
Kliniske studier for Akut lymfoblastisk leukemi i Indiana
6 studier for Akut lymfoblastisk leukemi søker deltakere på steder i Indiana.
Byer i Indiana
Offisiell studietekst (engelsk)
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- Reid Health, Richmond
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
Alder 40 til 75 · Alle kjønn · Oppdatert 2. okt. 2026 · NCT05334069First-in-human Study of a New Treatment (4A10) for Patients With Relapsed or Hard-to-treat Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma, Focused on Safety and How the Drug Behaves in the Body and Early Signs of Effect.
- Riley Children's Hosptial, Indianapolis
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 1. sep. 2026 · NCT07586618The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
- Riley Hospital for Children, Indianapolis
- Ascension Saint Vincent Indianapolis Hospital, Indianapolis
RekruttererFase 1/2
Opp til 22 år · Alle kjønn · Oppdatert 25. aug. 2026 · NCT04726241A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
- Indiana University/Riley Hospital for Children, Indianapolis
RekruttererObservasjonsstudie
Alle aldre · Alle kjønn · Oppdatert 6. jul. 2026 · NCT01351545A Study of Olverembatinib in Patients With Newly Diagnosed Ph+ ALL (POLARIS-1)
- Ascentage Investigative Site #1158, Indianapolis
- Ascentage Investigative Site #1069, Indianapolis
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 30. apr. 2026 · NCT06051409Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies
- Riley Hospital for Children, Indianapolis
RekruttererFase 1
Alder 1 til 21 · Alle kjønn · Oppdatert 6. des. 2024 · NCT05476770Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.